{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:45:40Z","timestamp":1767980740525,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clgc.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T23:17:50Z","timestamp":1530832670000},"page":"e1123-e1132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic Value of Serum Cholinesterase in Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Shoji","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7864-408X","authenticated-orcid":false,"given":"Beat","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6603-6319","authenticated-orcid":false,"given":"Mohammad","family":"Abufaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai D.","family":"Vartolomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-2458","authenticated-orcid":false,"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kilian M.","family":"Gust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2018.07.002_bib1","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2018.07.002_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2012.09.057","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers","volume":"63","author":"Kamat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib4","doi-asserted-by":"crossref","first-page":"113.e9","DOI":"10.1016\/j.urolonc.2016.10.021","article-title":"Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer","volume":"35","author":"Soria","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.07.002_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.6004\/jnccn.2017.0156","article-title":"Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Spiess","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clgc.2018.07.002_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bju.13146","article-title":"Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","volume":"117","author":"Moschini","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2018.07.002_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00345-011-0709-9","article-title":"Impact of gender on bladder cancer incidence, staging, and prognosis","volume":"29","author":"Fajkovic","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib10","doi-asserted-by":"crossref","first-page":"8.e17","DOI":"10.1016\/j.urolonc.2017.08.027","article-title":"Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer","volume":"36","author":"Rieken","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.07.002_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.eururo.2006.06.010","article-title":"Precystectomy nomogram for prediction of advanced bladder cancer stage","volume":"50","author":"Karakiewicz","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2006.11.004","article-title":"Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy","volume":"51","author":"Nielsen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib13","first-page":"68","article-title":"Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer","volume":"183","author":"Shariat","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/modpathol.3800757","article-title":"Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness","volume":"20","author":"Shariat","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2018.07.002_bib15","first-page":"1473","article-title":"E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup","volume":"165","author":"Byrne","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib16","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1158\/1078-0432.CCR-06-1472","article-title":"Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease","volume":"12","author":"Margulis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2018.07.002_bib17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/cncr.22521","article-title":"Survivin expression is associated with bladder cancer presence, stage, progression, and mortality","volume":"109","author":"Shariat","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2018.07.002_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPA.0b013e31815b6b2b","article-title":"Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion","volume":"36","author":"Mitsunaga","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.clgc.2018.07.002_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1665-2681(19)30932-9","article-title":"Association between butyrylcholinesterase activity and low-grade systemic inflammation","volume":"11","author":"Lampon","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clgc.2018.07.002_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/0973-1482.165869","article-title":"Serum butyrylcholinesterase and zinc in breast cancer","volume":"13","author":"Kumar","year":"2017","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.clgc.2018.07.002_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","article-title":"Butyrylcholinesterase as a prognostic marker: a review of the literature","volume":"4","author":"Santarpia","year":"2013","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clgc.2018.07.002_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.urolonc.2014.03.010","article-title":"Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy","volume":"32","author":"Koie","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.07.002_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2018.07.002_bib24","first-page":"71","article-title":"Serum pseudocholinesterase activity during experimental fattening","volume":"14","author":"Popescu","year":"1976","journal-title":"Med Interne"},{"key":"10.1016\/j.clgc.2018.07.002_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2459\/JCM.0b013e3283627700","article-title":"Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults","volume":"15","author":"Vallianou","year":"2014","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.clgc.2018.07.002_bib26","first-page":"158","article-title":"[Protein-energy malnutrition: its effects on 4 metabolic parameters]","volume":"10","author":"Camarero Gonzalez","year":"1995","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clgc.2018.07.002_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MPH.0000000000000828","article-title":"Butyrylcholinesterase as a blood biomarker in neuroblastoma","volume":"39","author":"Coulter","year":"2017","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clgc.2018.07.002_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4066\/AMJ.2011.569","article-title":"Significance of serum butyrylcholinesterase levels in oral cancer","volume":"4","author":"Prabhu","year":"2011","journal-title":"Australas Med J"},{"key":"10.1016\/j.clgc.2018.07.002_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biopha.2011.11.005","article-title":"Cholinesterase activities and biochemical determinations in patients with prostate cancer: influence of Gleason score, treatment and bone metastasis","volume":"66","author":"Battisti","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clgc.2018.07.002_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/jjco\/hyx168","article-title":"Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy","volume":"48","author":"Noro","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clgc.2018.07.002_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib32","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2018.07.002_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2009.09.024","article-title":"Characteristics and outcomes of\u00a0patients with clinical T1 grade 3 urothelial carcinoma treated with radical\u00a0cystectomy: results from an international cohort","volume":"57","author":"Fritsche","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.002_bib34","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.humpath.2006.05.017","article-title":"Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis","volume":"37","author":"Shariat","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clgc.2018.07.002_bib35","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0090-4295(03)00236-X","article-title":"Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder","volume":"61","author":"Shariat","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2018.07.002_bib36","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","article-title":"Challenges of cancer biomarker profiling","volume":"52","author":"Bensalah","year":"2007","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318304154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318304154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:29:49Z","timestamp":1761564589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767318304154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1558767318304154"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2018.07.002","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of Serum Cholinesterase in Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}